SPRING Vision

Company Overview

Snapshot

Founded in January 2015, SPRING Vision operated with 11–50 employees. The company's core innovation was recognized with an ophthalmic equipment design aimed at comprehensive patient diagnosis.

Business overview

SPRING Vision developed noninvasive, real-time, multispectral retinal imaging technology for automated diagnostics of ocular and systemic diseases. The company's technology, including the iCapture45 and the upcoming iCapture75, allowed physicians to differentiate between healthy and early-stage diseased retinal blood vessels, and evaluated novel technology for portraying a retinal oxygenation map. Leveraging AI, this microangiography combined with retinal tissue oximetry aimed to revolutionize diagnostic ability and clinical application in retinal imaging, serving the healthcare sector, particularly providers, within the Health Tech & Life Sciences industry.

Company Intelligence Q&A

What is SPRING Vision's primary focus?

SPRING Vision focuses on developing noninvasive, real-time, multispectral retinal imaging technology for automated diagnostics of ocular and systemic diseases.

What product did SPRING Vision develop?

SPRING Vision developed the iCapture45, a non-mydriatic and mydriatic multispectral retinal imager with a 45-degree field of view, utilizing its proprietary technology. The company was also working on the iCapture75, a mydriatic imager with a larger field of view.

What technologies does SPRING Vision utilize?

SPRING Vision utilizes machine learning, artificial intelligence, and data analytics in its digital healthcare solutions, specifically in ophthalmology and medical devices.

What was the status of SPRING Vision's operations?

SPRING Vision ceased to operate in November 2025.

What was a key technological achievement for SPRING Vision?

In 2015, SPRING Vision designed ophthalmic equipment intended to offer overall patient diagnosis, focusing on eye diseases, digital healthcare, medical devices, ophthalmology, and diagnostics.